NCT07477444 2026-03-17
HER-OIC
Universitaire Ziekenhuizen KU Leuven
Phase 1/2 Not yet recruiting
Clinical Trials
21 trialsNCT04868877 2026-02-19
Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination
Merus B.V.
Phase 1/2 Active not recruiting
NCT05731947 2026-01-29
Evaluation of Revumenib in Participants With Colorectal Cancer and Other Solid Tumors
Syndax Pharmaceuticals
Phase 1/2 Completed
NCT07342725 2026-01-15
Phase Ib/II Study to Evaluate the Safety and Efficacy of IBI363 in Combination With Chemotherapy as Second-Line Therapy for Unresectable Locally Advanced or Metastatic Pancreatic Cancer
Ruijin Hospital
Phase 1/2 Not yet recruiting
NCT07291947 2025-12-18
PULSAR Combined With Immunotherapy and Chemotherapy
West China Hospital
Phase 1/2 Recruiting
NCT04888312 2025-10-08
OPTIMIZE-1
Alligator Bioscience AB
Phase 1/2 Active not recruiting
NCT06758544 2025-08-17
A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Resectable Pancreatic Cancer
Guangdong Provincial People's Hospital
Phase 1/2 Recruiting
NCT02327078 2025-08-14
A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)
Incyte Corporation
Phase 1/2 Completed
NCT06844422 2025-02-25
Adapted Guided Stereotactic Body Radiotherapy Combined with Chemotherapy and Enhancement of Novel Drug Ivonescimab for Pancreatic Cancer (ASCEND)
Shandong Cancer Hospital and Institute
Phase 1/2 Recruiting
NCT05101616 2024-03-07
A Pilot Study of Neoadjuvant Chemotherapy With or Without Camrelizumab for Locally Advanced Gastric Cancer
Shanghai Minimally Invasive Surgery Center
Phase 1/2 Suspended
NCT04558684 2024-01-03
Radiotherapy With Neoadjuvant Chemotherapy and Immunotherapy in Rectal Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 1/2 Suspended
NCT06173986 2023-12-18
Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal Cancer
Shanghai Chest Hospital
Phase 1/2 Recruiting
NCT03544736 2023-03-22
Safety and Feasibility of Irradiation and Nivolumab in Esophageal Cancer (INEC)
Oslo University Hospital
Phase 1/2 Active not recruiting
NCT05198856 2022-01-20
Thalidomide Combined With Chemotherapy and Monotherapy for Maintenance Treatment for Her2-negative Advanced GC
Qilu Hospital of Shandong University
Phase 1/2 Unknown
NCT03985891 2020-12-17
JSFOL
Xiangya Hospital of Central South University
Phase 1/2 Recruiting
NCT04410887 2020-06-01
Neoadjuvant Chemotherapy With PISOXO for Locally-invaded-gastric Cancer (LIGC)
Ruijin Hospital
Phase 1/2 Unknown
NCT01490996 2020-01-31
CUFOX
University of Leicester
Phase 1/2 Completed
NCT01975454 2018-04-19
Study of TLBZT Based Herbal Therapy Plus Chemotherapy for Metastatic Colorectal Cancer
Shanghai University of Traditional Chinese Medicine
Phase 1/2 Completed
NCT02873520 2016-10-07
Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer
Ningbo Cancer Hospital
Phase 1/2 Unknown
NCT00179816 2010-10-11
Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors
Ann & Robert H Lurie Children's Hospital of Chicago
Phase 1/2 Unknown
NCT00041808 2005-06-24
Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver
FeRx
Phase 1/2 Completed